We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > sales volume

News List

J&J loses yet another fight to protect Zytiga from generics fiercepharma
November 27, 2018
Johnson & Johnson lost its latest effort to fend off Zytiga generics in court, sending investors reeling at the prospect of losing blockbuster sales. But the pharma giant says it’s now planning a last-ditch stand at the U.S. Supreme Court.
In swap for faster UK launches, pharma caps sales growth at 2% fiercepharma
November 27, 2018
How much are pharma companies willing to pay in exchange for a faster trip to market in the U.K.? As it turns out, a cap of 2% on total branded-drug sales growth should do. And that’s a deal the industry is billing as a big savings for the government next
Teva raises earnings estimates despite continuing troubles pharmatimes
August 03, 2018
Teva has raised its annual earnings guidance as it reported a smaller-than-expected drop in profits for Q2, a good sign for the company's ongoing restructuring programme.